Description: Pharmaceutical Research and Manufacturers of America (PhRMA) is the U.S. trade association representing leading research-based pharmaceutical and biotechnology companies; it advocates for public policies that support medical innovation, drug discovery and development, and patient access to new medicines. Type: Trade association (non-profit industry association, commonly organized as a 501(c)(6)) Policies: Typically pursues legislative and regulatory policies that incentivize biopharmaceutical research and development, strengthen intellectual property and patent protections, streamline FDA regulatory pathways, shape reimbursement and pricing frameworks, support market access for innovative therapies, modernize clinical trial rules, and oppose measures it views as undermining innovation such as certain price controls or drug reimportation. Funding: Primarily funded by membership dues, fees, and contributions from member pharmaceutical and biotechnology companies, plus revenue from sponsored events and programs. Affiliates: Major member companies and industry partners, for example Pfizer, Merck, Johnson & Johnson, Eli Lilly, Amgen, AbbVie and Gilead Sciences, along with related industry groups and state pharmaceutical associations.
